• About
  • Photo Contest: AAPI Heritage Month
  • Community Calendar
  • Advertise
  • Subscriptions
  • Contact
  • Seattle Chinese Post

Northwest Asian Weekly


  • Community
    • Names in the News
    • Local
    • Business
    • Pictorials
    • Obituaries
  • Nation
  • World
  • Arts & Entertainment
  • Columns
    • On the Shelf
    • At the Movies
    • A-POP!
    • Publisher Ng’s blog
    • The Layup Drill
    • Travel
    • Wayne’s Worlds
  • Opinion
    • Editorial
    • Commentary
    • Publisher Ng’s blog
    • Letters to the Editor
  • Astrology
  • Classifieds
  • Community Calendar
You are here: Home / News / Community News / Keeping a positive outlook: Chinese American fights lung cancer

Keeping a positive outlook: Chinese American fights lung cancer

December 11, 2008 By Northwest Asian Weekly

By Staff
Northwest Asian Weekly

Lung cancer is the number one cause of cancer-related deaths in the United States and will kill more Americans this year than breast, prostate, colon, and liver cancers combined. The Chinese American population has the highest death rates for lung and bronchial cancer among all Asian American groups.

Lung cancer patient Ellen Chung refuses to let these statistics affect her positive outlook on life. Resilience is not a new concept for Chung. Born in Hawaii, her father worked in a sugar cane field. She was the fifth of six children.

She worked two jobs to follow her dream of moving to New York City after high school. Chung has since lived in four different cities, had four children, returned to college in her 30s, and is now retired and enjoying life as a grandmother.

Chung views her lung cancer diagnosis as just another hurdle in her life. She was diagnosed with stage IV non-small cell lung cancer (NSCLC) in December 2002. She never smoked, and her only symptoms were some indigestion and pain in her left chest and shoulder.

“My first oncologist gave me nine months to live and said the only effective treatment option was chemotherapy, which may or may not give me more time — I decided to try another oncologist,” Chung said.

According to Chung’s current oncologist, Dr. Nick Chen, M.D., Ph.D., at the Seattle Cancer Treatment and Wellness Center, there are currently four standard treatments for lung cancer — surgery, radiation, chemotherapy and targeted therapies.

However, when Chung was initially diagnosed, her options were more limited.

Chung’s stage IV cancer initially responded well to chemotherapy, but the cancer eventually returned. When the drug Tarceva (generic name of the drug is erlotinib) was approved, Chen recommended this treatment for Chung.

“Now, almost six years later, I take a pill once a day, which allows me to continue living my life,” Chung said.
“In recent years, there have been advances in lung cancer treatment, including targeted
therapies like Tarceva that allow us to specifically attack the cancer cells,” said Chen. “Studies have been conducted showing the benefit of Tarceva in non-smoking Chinese American women, like Ellen, who has had a positive response.”

After years of working and caring for others, Chung has learned to take time for herself. She enjoys reading, and has discovered gardening, sewing, and baking — hobbies she used to be too busy to enjoy. ♦

For more information on lung cancer and treatment options, visit www.lungcanceralliance.org, www.tarceva.com and www.seattlecancerwellness.com.

Share:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Related

Filed Under: Community News Tagged With: 2008, Asian American, Chinese American, Ellen Chung, NSCLC, New York City, Nick Chen, Northwest Asian Weekly, United States, Vol 27 No 51 | December 13 - December 19

  • Facebook
  • Instagram
  • RSS
  • Twitter
  • YouTube

Find us on Issuu!

Subscribe to our e-news

© 2022 NORTHWEST ASIAN WEEKLY
412 MAYNARD AVE. S., SEATTLE, WA 98104
206-223-5559 | INFO@NWASIANWEEKLY.COM